Black Women's Higher Breast Cancer Mortality Rates

Breast cancer mortality rates among Black women in the United States are significantly higher than those among White women, despite Black women having a slightly lower incidence of the disease1 . This disparity has persisted and even widened since the 1980s, largely due to differences in tumor biology and unequal access to early detection and effective treatments1 . Understanding the complex factors behind these disparities is essential for improving outcomes and reducing mortality among Black women2 .

Breast Cancer Subtypes and Racial Disparities

Breast cancer is a heterogeneous disease classified into subtypes based on the presence or absence of hormone receptors—estrogen receptor (ER), progesterone receptor (PR)—and human epidermal growth factor receptor 2 (HER2) status3 . These subtypes differ in tumor biology, prognosis, and treatment response4 . The main molecular subtypes include:

• Hormone receptor-positive/HER2-negative (HR+/HER2−)
• Hormone receptor-positive/HER2-positive (HR+/HER2+)
• Hormone receptor-negative/HER2-positive (HR−/HER2+)
• Triple-negative breast cancer (TNBC), which lacks ER, PR, and HER2 expression3 4

TNBC is the most aggressive subtype with limited treatment options and poorer prognosis3 4. Black women have a disproportionately higher incidence of TNBC compared to White women, while they have a lower incidence of hormone receptor-positive/HER2-negative tumors3 4. This higher prevalence of aggressive subtypes contributes to the elevated mortality rates seen in Black women3 . However, disparities in survival persist even within the same breast cancer subtypes, indicating that tumor biology alone does not fully explain the mortality gap3 4.

Additional factors influencing subtype distribution and outcomes include genetic ancestry and environmental exposures, which may affect the development of specific breast cancer types3 . For example, Black women have a higher rate of hormone receptor-negative tumors, which are harder to detect and treat effectively5 .

💡 Did You Know? The percentage of breast cancer mortality among Black women is about 42% higher compared to White women. Breast cancer survival rates have remained lower among White women but have increased over time in Black women6 .

Higher Mortality Gaps in Specific Breast Cancers

Recent studies have demonstrated that Black women experience higher mortality rates from breast cancer across all molecular subtypes, even after controlling for tumor biology3 4. The mortality gap is most pronounced in hormone receptor-positive/HER2-negative and hormone receptor-positive/HER2-positive breast cancers, subtypes generally associated with better prognosis and more treatment options3 4. However, Black women also have higher mortality rates in hormone receptor-negative subtypes, including TNBC3 4.

Key findings include:

Community health worker and patient navigator models have shown promise in decreasing breast cancer screening disparities among Black women by providing education, support, and assistance navigating the healthcare system. These culturally tailored interventions can help overcome barriers related to access and trust. 9

• Black women have a 17% to 50% higher risk of death from breast cancer than White women, depending on the subtype5 .
• The mortality gap for hormone receptor-positive tumors is larger (34–50% higher risk) compared to hormone receptor-negative tumors (17–20% higher risk) 7.
• Despite hormone receptor-positive breast cancer being more amenable to early detection via mammography and having a wider range of therapies, disparities in outcomes remain significant3 4.
• The higher mortality rates among Black women cannot be fully explained by tumor subtype incidence, suggesting that non-biological factors play a critical role3 4.

These disparities highlight the need to address factors beyond tumor biology, such as access to care, socioeconomic status, and systemic barriers, to reduce mortality gaps3 4.

“Our findings demonstrate that multiple, interacting factors contribute to disparities in breast cancer survival between Black and white women.”

— Erica Warner, ScD, MPH, Massachusetts General Hospital7

Causes of Breast Cancer Disparities

“Coordinated and concerted efforts by policy makers, healthcare systems, and providers are needed to provide optimal breast cancer care to all populations and reduce breast health disparity and accelerate progress against the disease.”

— Ahmedin Jemal, DVM, PhD, American Cancer Society2

The persistent racial disparities in breast cancer mortality are multifactorial, involving both biological and non-biological contributors. While Black women have a higher incidence of aggressive tumor subtypes like TNBC, this alone does not fully explain the mortality differences3 4. Key causes include:

• Socioeconomic Inequality: Black women are more likely to face poverty, lower educational attainment, and limited resources, which affect their ability to access timely and quality healthcare5 3.
• Access to Care: Black women experience disparities in health insurance coverage, leading to delays in diagnosis and treatment1 3. They are also less likely to receive guideline-concordant care and advanced therapies3 4.
• Screening and Early Detection: Black women are more likely to be diagnosed at later stages of breast cancer, partly due to lower rates of regular mammography screening and barriers such as lack of insurance and healthcare access8 3. Black women living below the federal poverty line are almost twice as likely to be diagnosed with late-stage breast cancer compared to those above the poverty line8 .
• Biological Factors: Genetic ancestry may contribute to the higher prevalence of hormone receptor-negative and triple-negative breast cancers among Black women, but this is intertwined with social determinants1 .
• Breast Density: Black women tend to have denser breast tissue, which can make mammography less effective in detecting tumors early5 .

• Cultural and Structural Barriers: Factors such as mistrust of the healthcare system, lack of culturally competent care, and limited support for breastfeeding (which is protective against TNBC) contribute to disparities5 .

• Black women younger than age 50 have a breast cancer death rate twice as high as White women of the same age2 .

• The racial disparity in breast cancer mortality emerged sharply after 1980, coinciding with the introduction of mammography screening and adjuvant endocrine therapy, from which Black women derived less benefit due to unequal access1 .
• Social determinants of health, including structural racism and neighborhood environments, influence both cancer development and access to care1 .

“It is time for health systems to take a hard look at how they are caring differently for Black women.”

— Rebecca Siegel, MPH, American Cancer Society2

Solutions for Reducing Breast Cancer Mortality

Addressing the disparities in breast cancer mortality among Black women requires coordinated efforts targeting both biological and social factors. Effective strategies include:

• Improving Access to Quality Care: Expanding health insurance coverage and reducing financial barriers can facilitate timely diagnosis and treatment1 3.
• Enhancing Screening Programs: Community-based outreach and patient navigation models can increase mammography rates and early detection in underserved populations9 .
• Culturally Competent Care: Training healthcare providers to deliver culturally sensitive care and addressing mistrust can improve adherence and outcomes5 .
• Research on Aggressive Subtypes: Prioritizing research on TNBC and other aggressive breast cancers common in Black women is critical for developing targeted therapies1 .

• Addressing Social Determinants: Policies to reduce poverty, improve education, and support breastfeeding can indirectly reduce breast cancer risk and improve survival5 .

• Black women are more likely to be diagnosed with breast cancer at a younger age, highlighting the need for earlier screening and awareness3 4.

• Minority women, including Black, Hispanic, and American Indian/Alaska Native (AIAN) women, are more likely to be diagnosed with advanced-stage breast cancer, underscoring disparities in early detection3 4.
• Health insurance inequities disproportionately affect Black women, limiting access to mammography and high-quality treatment3 4.